Heparan sulfate 6-O-endosulfatases: Discrete in vivo activities and functional co-operativity

Biochemical Journal

Volumn 400, Issue 1, 2006, Pages 63-73

  Lamanna, William C ^a,b   Baldwin, Rebecca J ^c   Padva, Michael ^b   Kalus, Ina ^a   Ten Dam, Gerdy ^d   Van Kuppevelt, Toin H ^d   Gallagher, John T ^c   Von Figura, Kurt ^b   Dierks, Thomas ^a   Merry, Catherine L R ^c  

^a BIELEFELD UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endosulfatase; Glycosaminoglycan; Heparan sulfate; Knock out mice; Signal transduction; Sulfatase

Indexed keywords

BIOASSAY; ENZYMES; POLYMERS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL); TISSUE;

ENDOSULFATASES; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; KNOCK-OUT MICE; SIGNAL TRANSDUCTION; SULFATASES;

ENZYME KINETICS;

FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; HEPARAN SULFATE 6 O ENDOSULFATASE DERIVATIVE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; IN VIVO CULTURE; MITOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES; CELL PROLIFERATION; CELLS, CULTURED; DISACCHARIDES; EPITOPES; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENOTYPE; HEPARITIN SULFATE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOLECULAR STRUCTURE; OLIGOSACCHARIDES; SULFATASES; SULFATES; SULFOTRANSFERASES;

AVES; MAMMALIA; MURINAE;

EID: 33751083837     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060848     Document Type: Article

References (34)

1. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J. and Zako, M. (1999) Functions of cell surface heparin sulphate proteoglycans. Annu. Rev. Biochem. 68, 729-777
2. Rapraeger, A. C., Krufka, A. and Olwin, B. B. (1991) Requirement of heparin sulphate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708
3. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. and Ornitz, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848
4. Esko, J. D. and Lindahl, U. (2001) Molecular diversity of heparin sulfate. J. Clin. Invest. 108, 169-173
5. Ledin, J., Staatz, W., Li, J. P., Gotte, M., Selleck, S., Kjellen, L. and Spillmann, D. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 279, 42732-42741
6. Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K. and Lindahl, U. (1996) Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 271, 17804-17810
7. Pye, D. A., Vives, R. R., Hyde, P. and Gallagher, J. T. (2000) Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology 10, 1183-1192
8. Brickman, Y. G., Ford, M. D., Gallagher, J. T., Nurcombe, V., Bartlett, P. F. and Turnbull, J. E. (1998) Structural modification of fibroblast growth factor-binding heparin sulphate at a determinative stage of neural development. J. Biol. Chem. 273, 4350-4359
9. Jayson, G. C., Vives, C., Paraskeva, C., Schofield, K., Coutts, J., Fleetwood, A. and Gallagher, J. T. (1999) Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int. J. Cancer. 82, 298-304
10. Dhoot, G. K., Gustafsson, M. K., Ai, X., Sun, W., Standiford, D. M. and Emerson, Jr, C. P. (2001) Regulation of Wnt signalling and embryo patterning by an extracellular sulfatase. Science 293, 1663-1666
11. Morimoto-Tomita, M., Uchimura, K., Werb, Z., Hemmerich, S. and Rosen, S. D. (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J. Biol. Chem. 277, 49175-49185
12. Ai, X., Do, A. T., Kusche-Gullberg, M., Lindahl, U., Lu, K. and Emerson, Jr, C. P. (2006) Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J. Biol. Chem. 281, 4969-4976
13. Ai, X., Do, A. T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U. and Emerson, Jr, C. P. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 162, 341-351
14. Viviano, B. L., Paine-Saunders, S., Gasiunas, N., Gallagher, J. and Saunders, S. (2004) Domain-specific modification of heparan sulfate by QSulf1 modulates the binding of the bone morphogenetic protein antagonist noggin. J. Biol. Chem. 279, 5604-5611
15. Wang, S., Ai, X., Freeman, S. D., Pownall, M. E., Lu, Q., Kessler, D. S. and Emerson, Jr, C. P. (2004) QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 4833-4838
16. Lai, J., Chien, J., Staub, J., Avula, R., Greene, E. L., Matthews, T. A., Smith, D. I., Kaufmann, S. H., Roberts, L. R. and Shridhar, V. (2003) Loss of HSulf-1 up regulates heparin-binding growth factor signaling in cancer. J. Biol. Chem. 278, 23107-23117
17. Li, J., Kleeff, J., Abiatari, I., Kayed, H., Giese, N. A., Felix, K., Giese, T., Buchler, M. W. and Friess, H. (2005) Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Mol. Cancer 4, 14
18. Morimoto-Tomita, M., Uchimura, K., Bistrup, A., Lum, D. H., Egeblad, M., Boudreau, N., Werb, Z. and Rosen, S. D. (2005) Sulf-2, a proangiogenic heparan sulfate endosulfatase, is up regulated in breast cancer. Neoplasia 7, 1001-1010
19. Lai, J. P., Chien, J., Strome, S. E., Staub, J., Montoya, D. P., Greene, E. L., Smith, D. I., Roberts, L. R. and Shridhar, V. (2004) HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23, 1439-1447
20. Lai, J. P., Chien, J. R., Moser, D. R., Staub, J. K., Aderca, I., Montoya, D. P., Matthews, T. A., Nagorney, D. M., Cunningham, J. M., Smith, D. I. et al. (2004) HSulf-1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 126, 231-248
21. Uchimura, K., Morimoto-Tomita, M., Bistrup, A., Li, J., Lyon, M., Gallagher, J., Werb, Z. and Rosen, S. D. (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 7, 2
22. -/- mutant mouse J. Biol. Chem. 276, 35429-35434
23. Schuermann, M. (1990) An expression vector system for stable expression of oncogenes. Nucleic Acids Res. 18, 4945-4946
24. Merry, C. L. R., Lyon, M., Deakin, J. A., Hopwood, J. J. and Gallagher, J. T. (1999) Highly sensitive sequencing of the sulfated domains of heparan sulphate. J. Biol. Chem., 274, 18455-18462
25. Mouritzen, P., Nielsen, P. S., Jacobsen, N., Noerholm, M., Lomholt, C., Pfundheller, H. M., Ramsing, N. B., Kauppinen, S. and Tolstrup, N. (2004) The probe library: expression profiling of 99 % of all human genes using only 90 dual labeled real time PCR probes. BioTechniques 37, 492-495
26. -ΔΔCT method. Methods 25, 402-408
27. Shively, J. E. and Conrad, H. E. (1976) Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942
28. Robinson, C. J., Mulloy, B., Gallagher, J. T. and Stringer, S. E. (2006) VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731-1740
29. Do, A. T., Smeds, E., Spillmann, D. and Kusche-Gullberg, M. (2005) Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation. J. Biol. Chem. 9, 5348-5356
30. Smeds, E., Habuchi, H., Do, A. T., Hjertson, E., Grundberg, H., Kimata, K., Lindahl, U. and Kusche-Gullberg, M. (2003) Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases. Biochem. J. 372, 371-380
31. van Kuppevelt, T. H., Dennissen, M. A., van Venrooij, W. J., Hoet, R. M. and Veerkamp, J. H. (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J. Biol. Chem. 273, 12960-12966
32. Dennissen, M. A., Jenniskens, G. J., Pieffers, M., Versteeg, E. M., Petitou, M., Veerkamp, J. H. and van Kuppevelt, T. H. (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277, 10982-10986
33. Jenniskens, G. J., Oosterhof, A., Brandwijk, R., Veerkamp, J. H. and van Kuppevelt, T. H. (2000) Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J. Neurosci. 20, 4099-4111
34. Raman, R., Sasisekharan, V. and Sasisekharan, R. (2005) Structural insights into biological roles of protein-glycosaminoglycan interaction. Chem. Biol. 12, 267-277